back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-04-04 Tx date 2016-03-31 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$229,200
+60,000 vol $3.82 each |
312,501 | |
| Filed 2015-09-09 Tx date 2014-07-18 |
$APS
Lorus Therapeutics Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$338,800
+770,000 vol $0.44 each |
2,310,000 | |
| Filed 2015-09-09 Tx date 2014-07-18 |
$APS
Lorus Therapeutics Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$338,800
+770,000 vol $0.44 each |
||
| Filed 2015-09-09 Tx date 2014-07-18 |
$APS
Lorus Therapeutics Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$334,950
+770,000 vol $0.435 each |
||
| Filed 2015-06-11 Tx date 2015-06-10 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$417,600
+60,000 vol $6.96 each |
252,501 | |
| Filed 2015-05-27 Tx date 2015-05-26 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,720
+800 vol $5.90 each |
3,400 | |
| Filed 2015-05-27 Tx date 2015-05-26 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,892
+500 vol $5.78 each |
3,900 | |
| Filed 2015-05-27 Tx date 2015-05-26 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,740
+300 vol $5.80 each |
4,200 | |
| Filed 2015-05-13 Tx date 2015-05-12 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,130
+700 vol $5.90 each |
2,600 | |
| Filed 2015-05-13 Tx date 2015-05-12 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,720
+800 vol $5.90 each |
1,400 | |
| Filed 2015-05-13 Tx date 2015-05-12 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,925
+500 vol $5.85 each |
1,900 | |
| Filed 2015-05-12 Tx date 2015-05-11 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,812
+300 vol $6.04 each |
600 | |
| Filed 2015-05-12 Tx date 2014-10-01 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,117,499 vol |
192,501 | |
| Filed 2015-05-12 Tx date 2015-05-11 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,782
+300 vol $5.94 each |
300 | |
| Filed 2015-05-12 Tx date 2013-11-29 |
$APS
Aptose Biosciences Inc. |
Vellanki, Avanish
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|